Literature DB >> 31490106

Robust LC-MS/MS methods for analysis of heparan sulfate levels in CSF and brain for application in studies of MPS IIIA.

Åsa Makower1, Erik Arnelöf1, Tommy Andersson1, Per-Olof Edlund1, Susanne Gustavsson1, Juliette Janson1, Stefan Svensson Gelius1, Agneta Tjernberg1.   

Abstract

Aim: Accumulation of heparan sulfate (HS) is associated with the neurodegenerative disorder Mucopolysaccharidosis type IIIA (MPS IIIA). Here, we compare HS levels in brain and cerebrospinal fluid (CSF) of MPS IIIA mice after treatment with a chemically modified sulfamidase (CM-rhSulfamidase). Materials & methods: Two LC-MS/MS methods were adapted from literature methodology, one to measure HS metabolites (HSmet), the other to measure digests of HS after heparinase treatment (HSdig).
Results: The HSmet and HSdig methods showed similar relative reduction of HS in brain after CM-rhSulfamidase administration to MPS IIIA mice and the reduction was reflected also in CSF.
Conclusion: The results of the two methods correlated and therefore the HSdig method can be used in clinical studies to determine HS levels in CSF from patients with MPS IIIA.

Entities:  

Keywords:  3-methyl-1-phenyl-2-pyrazolino-5-one derivatization; LC–MS/MS; cerebrospinal fluid; enzyme replacement therapy; glycosaminoglycans; heparan sulfate; heparinase; lysosomal storage; mucopolysaccharidosis; multiple reaction monitoring

Mesh:

Substances:

Year:  2019        PMID: 31490106     DOI: 10.4155/bio-2019-0095

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

1.  Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving rats.

Authors:  Juliette Janson; Gudrun Andersson; Lars Bergquist; Maria Eriksson; Joost H A Folgering
Journal:  Mol Genet Metab Rep       Date:  2019-12-27

2.  High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II.

Authors:  Junhua Wang; Akhil Bhalla; Julie C Ullman; Meng Fang; Ritesh Ravi; Annie Arguello; Elliot Thomsen; Buyankhishig Tsogtbaatar; Jing L Guo; Lukas L Skuja; Jason C Dugas; Sonnet S Davis; Suresh B Poda; Kannan Gunasekaran; Simona Costanzo; Zachary K Sweeney; Anastasia G Henry; Jeffrey M Harris; Kirk R Henne; Giuseppe Astarita
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.